Volume 11, Number 5—May 2005
Dispatch
Human T-cell Leukemia Virus Type 1 Molecular Variants, Vanuatu, Melanesia
Table 2
Country of origin | Age (y) | Sex | Birth | Residence | Clinical status | Virus name | env GenBank accession no. | LTR GenBank accession no. |
---|---|---|---|---|---|---|---|---|
Vanuatu | 45 | F | Ambae | Filakalaka | AC | HTLV-1 VAN 54 | AY549879 | AY549875 |
36 | F | Ambae | Ndui Ndui | AC | HTLV-1 VAN 136 | AY549880 | AY549876 | |
42 | F | Ambae | Vinangwangwe | AC | HTLV-1 VAN 251 | AY549881 | AY549877 | |
42 | F | Ambae | Lolobinanungwa | AC | HTLV-1 VAN 335 | AY549882 | AY549878 | |
Papua New Guinea | 21 | M | Madang | Madang | AC | HTLV-1 MEL 1 | L02533 | NA |
60 | F | Madang | Madang | AC | HTLV-1 MEL 2 | M94197 | NA | |
31 | M | Madang | Madang | AC | HTLV-1 MEL 7 | U11576 | NA | |
Solomon Islands | 39 | F | New Georgia | Guadalcanal | AC | HTLV-1 MEL 3 | M94198 | NA |
60 | F | Guadalcanal | Guadalcanal | AC | HTLV-1 MEL 4 | M94199 | NA | |
58 | M | Guadalcanal | Guadalcanal | AC | HTLV-1 MEL 5 | M94200 | L02534 | |
38 | M | Guadalcanal | Guadalcanal | TSP/HAM | HTLV-1 MEL 6 | M93099 | NA | |
49 | M | New Georgia | Guadalcanal | AC | HTLV-1 MEL 8 | U11578 | NA | |
75 | M | Rendova | Guadalcanal | AC | HTLV-1 MEL 9 | U11580 | NA | |
13 | F | Guadalcanal | Guadalcanal | AC | HTLV-1 MEL 10 | U11566 | NA | |
42 | F | Guadalcanal | Guadalcanal | AC | HTLV-1 MEL 11 | U11568 | NA | |
60 | F | Guadalcanal | Guadalcanal | AC | HTLV-1 MEL 12 | U11570 | NA | |
Australia | NA | NA | NA | NA | AC | HTLV-1 MSHR-1 | M92818 | NA |
*LTR, long terminal repeat; F, female; M, male; AC, Asymptomatic carrier; TSP/HAM, tropical spastic paraparesis/HTLV-1–associated myelopathy; NA, not available.
Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.